RINALDI, SILVIA
 Distribuzione geografica
Continente #
NA - Nord America 2.524
EU - Europa 845
AS - Asia 796
SA - Sud America 138
AF - Africa 89
Continente sconosciuto - Info sul continente non disponibili 63
OC - Oceania 1
Totale 4.456
Nazione #
US - Stati Uniti d'America 2.488
SG - Singapore 281
VN - Vietnam 169
RU - Federazione Russa 143
IT - Italia 142
CN - Cina 137
BR - Brasile 116
DE - Germania 89
UA - Ucraina 87
IE - Irlanda 80
SE - Svezia 78
HK - Hong Kong 68
CI - Costa d'Avorio 62
FI - Finlandia 59
FR - Francia 50
TR - Turchia 42
GB - Regno Unito 41
IN - India 31
DK - Danimarca 24
CA - Canada 21
PL - Polonia 18
BD - Bangladesh 14
KR - Corea 14
AR - Argentina 12
NL - Olanda 12
JP - Giappone 10
MA - Marocco 10
ZA - Sudafrica 10
IQ - Iraq 6
ES - Italia 5
LT - Lituania 5
MX - Messico 5
AZ - Azerbaigian 3
BE - Belgio 3
CO - Colombia 3
ID - Indonesia 3
IL - Israele 3
KE - Kenya 3
PK - Pakistan 3
UZ - Uzbekistan 3
AL - Albania 2
BY - Bielorussia 2
CR - Costa Rica 2
JM - Giamaica 2
MY - Malesia 2
PR - Porto Rico 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
AT - Austria 1
AU - Australia 1
BB - Barbados 1
BF - Burkina Faso 1
BG - Bulgaria 1
CH - Svizzera 1
CL - Cile 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DZ - Algeria 1
EC - Ecuador 1
EG - Egitto 1
EU - Europa 1
HN - Honduras 1
IR - Iran 1
KG - Kirghizistan 1
KW - Kuwait 1
LV - Lettonia 1
NI - Nicaragua 1
PE - Perù 1
PH - Filippine 1
PY - Paraguay 1
SA - Arabia Saudita 1
SV - El Salvador 1
TN - Tunisia 1
VE - Venezuela 1
Totale 4.394
Città #
Ashburn 428
Chandler 236
Singapore 202
Fairfield 168
Jacksonville 135
Dublin 80
Seattle 80
San Jose 78
New York 76
Wilmington 73
Houston 71
Hong Kong 68
Woodbridge 67
Boardman 65
Abidjan 62
Los Angeles 62
Dallas 58
Des Moines 57
Ho Chi Minh City 57
Cambridge 50
Council Bluffs 50
Beijing 41
Hanoi 39
Munich 39
The Dalles 37
Turku 34
Ann Arbor 31
Lawrence 30
Princeton 30
Lauterbourg 29
San Mateo 29
Moscow 24
Turin 21
Milan 19
Washington 18
Buffalo 16
Warsaw 16
São Paulo 15
Helsinki 14
Santa Clara 14
Chicago 13
Orem 13
San Diego 13
Chennai 12
Da Nang 11
Montreal 11
London 10
Poplar 10
Brooklyn 9
Rio de Janeiro 9
Tokyo 9
Hefei 8
Johannesburg 8
Norwalk 8
Phoenix 8
Shanghai 8
Amsterdam 7
Atlanta 7
Columbus 7
Denver 7
Haiphong 7
Rome 7
Ancona 6
Pune 6
Ankara 5
Boston 5
Falls Church 5
Miano 5
Saint Louis 5
Avon 4
Baghdad 4
Bến Tre 4
Frankfurt am Main 4
Baku 3
Can Tho 3
Castelraimondo 3
Charlotte 3
Cleveland 3
Guangzhou 3
Jiaxing 3
Kilburn 3
Maceió 3
Miami 3
Montegiorgio 3
Nairobi 3
Stockholm 3
Tampa 3
Tashkent 3
Toronto 3
Vũng Tàu 3
Wuhan 3
Anápolis 2
Baytown 2
Bengaluru 2
Brussels 2
Casablanca 2
Chengdu 2
City of London 2
Concord 2
Detroit 2
Totale 3.046
Nome #
Electrolyte disorders in advanced non-small cell lung cancer patients treated with immune check-point inhibitors: a systematic review and meta-analysis 255
The prognostic and predictive role of hyponatremia in patients with advanced non-small cell lung cancer (NSCLC) with bone metastases 189
The role of an immune checkpoint score in resected non-small cell lung cancer patients' prognosis 167
Hyponatremia normalization as an independent prognostic factor in patients with advanced non-small cell lung cancer treated with first-line therapy 164
Pre-treatment systemic immune-inflammation represents a prognostic factor in patients with advanced non-small cell lung cancer 163
Electrolyte disorders in cancer patients: a systematic review 162
A multicenter study of body mass index in cancer patients treated with anti-PD-1/PD-L1 immune checkpoint inhibitors: When overweight becomes favorable 159
Correlations Between the Immune-related Adverse Events Spectrum and Efficacy of Anti-PD1 Immunotherapy in NSCLC Patients 156
Weighing the prognostic role of hyponatremia in hospitalized patients with metastatic solid tumors: the HYPNOSIS study 155
Incidence and risk of cardiotoxicity in cancer patients treated with targeted therapies 153
High CTLA-4 expression correlates with poor prognosis in thymoma patients 153
Managing hyponatremia in lung cancer: latest evidence and clinical implications 152
Hyponatremia is a predictor of hospital length and cost of stay and outcome in cancer patients. 150
Clinical and pathologic predictors of clinical outcome of malignant pleural mesothelioma 150
Gastrointestinal neuroendocrine tumors: Searching the optimal treatment strategy-A literature review 149
Impact of phosphoinositide-3-kinase and vitamin D3 nuclear receptor single-nucleotide polymorphisms on the outcome of malignant melanoma patients 149
Another side of the association between body mass index (BMI) and clinical outcomes of cancer patients receiving programmed cell death protein-1 (PD-1)/ Programmed cell death-ligand 1 (PD-L1) checkpoint inhibitors: A multicentre analysis of immune-related adverse events 147
Systemic treatment for lung carcinoids: from bench to bedside 145
Hyponatremia in cancer patients: Time for a new approach 143
Increased rates of local complication of central venous catheters in the targeted anticancer therapy era: a 2-year retrospective analysis. 143
Medical treatment for gastro-entero-pancreatic neuroendocrine tumours 138
Clinical Outcomes of Patients with Advanced Cancer and Pre-Existing Autoimmune Diseases Treated with Anti-Programmed Death-1 Immunotherapy: A Real-World Transverse Study 137
Risk of hyponatraemia in cancer patients treated with targeted therapies: A systematic review and meta-analysis of clinical trials 135
Evaluating the role of FAMIly history of cancer and diagnosis of multiple neoplasms in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: the multicenter FAMI-L1 study 134
Gastro-entero-pancreatic neuroendocrine tumors: Is now time for a new approach? 123
Syndrome of inappropriate antidiuresis in prostate adenocarcinoma with neuroendocrine differentiation: a case report and literature review 121
The Formidable Metamorphosis of the Salamander’s Wool: Asbestos from Eternal Material to Awful Pathologies 118
Prognostic models to predict survival in patients with advanced non-small cell lung cancer treated with first-line chemo- or targeted therapy 117
Lung cancer prognosis: Can histological patterns and morphological features have a role in the management of lung cancer patients? 116
Treatment of advanced small cell lung cancer 113
Totale 4.456
Categoria #
all - tutte 20.152
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.152


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022211 0 34 16 1 4 25 7 14 19 26 26 39
2022/2023622 34 86 36 72 20 113 0 43 142 0 61 15
2023/2024371 52 7 32 14 49 110 4 41 0 15 0 47
2024/2025603 84 49 16 3 36 31 56 26 102 37 79 84
2025/20261.576 145 77 54 212 196 139 267 153 106 131 26 70
2026/2027141 51 90 0 0 0 0 0 0 0 0 0 0
Totale 4.456